/About Us
About Us 2020-10-02T14:38:43+00:00

About Us

Hypertension Canada is the only national non-profit organization dedicated solely to the prevention and control of hypertension and its complications. Select from the following links to learn more about our:

We work with leading minds across medical and health disciplines to advance research and professional and public education, and with policy makers to ensure Canadians can avoid the potentially deadly complications of hypertension.

Seven and a half million people in Canada, about 1 in 5 adults, live with hypertension. Rising blood pressure over the long term causes atherosclerosis – the main risk for premature death (before the age of 65).

Canada has become a leader in the early detection of high blood pressure, its treatment and overall management.  Much of this success has been attributed to the Hypertension Canada Guidelines – a set of clinical practice guidelines which are rigorously reviewed and updated annually, providing health care professionals with the most up-to-date recommendations and guidelines for the detection, treatment and control of hypertension.

Despite recent achievements, 1 in 3 people with hypertension has uncontrolled blood pressure, particularly high-risk patients with diabetes and kidney disease; and almost 1 in 5 people with hypertension is unaware of their condition.

Mission & Vision


Advancing health through the prevention and control of high blood pressure and its complications.


Canadians will have the healthiest and best-managed blood pressure in the world.

Hypertension Canada delivers against mission/vision by striving for excellence in three core service areas:

  • Research: knowledge generation through research and innovation.
  • Education: knowledge translation by turning discovery into practice.
  • Advocacy: Creating supportive environments through healthy public policy and lifestyles.

Charitable Registration Number: 897016275RR0001


Board of Directors:

Edmonton, Alberta

Dr. Ross Tsuyuki is Professor and Chair, Department of Pharmacology in the Faculty of Medicine and Dentistry, University of Alberta. He is also a Professor of Medicine (Cardiology) and Director of EPICORE Centre (a health research coordinating centre) and the Editor-in-Chief of the Canadian Pharmacists Journal. His clinical practice is in the Heart Function Clinic at the Mazankowski Alberta Heart Institute. Having previously served on Hypertension Canada’s Board of Directors, Dr. Tsuyuki was elected in 2019 and appointed Vice-President. He also serves as a Co-Chair of the Education & Implementation Committee and is a member of the Hypertension Canada Guidelines Committee. 

Dr. Tsuyuki’s interests are in clinical trials design and execution, hypertension, heart failure, community practice-based research, cardiovascular risk factors, and in the provision of support for clinical researchers through the EPICORE Centre. Dr. Tsuyuki has received several awards for teaching, as well as an appointment as a Fellow of the Canadian Society of Hospital Pharmacists, the American College of Cardiology and the Canadian Academy of Health Sciences.  In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association.

Oakville, Ontario

Mr. Trevor Hudson is a senior manager in the Business Tax Services group with Deloitte and is focused primarily on the P3 infrastructure and the alternative energy sectors. Mr. Hudson was elected to Hypertension Canada’s Board in 2014.

Mr. Hudson has more than 14 years of professional experience in public practice with Deloitte and focuses primarily on the P3 infrastructure and the alternative and renewable energy sectors providing tax advisory services to Canadian and foreign based clients on matters relating to general tax planning, corporate reorganizations, mergers and acquisitions, tax accounting, and tax compliance reporting. Previously, Mr. Hudson worked in Deloitte’s assurance and advisory practice providing audit and accounting services to large public multinational clients as well as small medium and large private companies across a range of industries, including manufacturing, oil and gas, financial services, and not-for-profits. Mr. Hudson is the chair of Deloitte’s United Way employee campaign.

In addition to working in public practice, Mr. Hudson has also worked in the capital markets group of a large Canadian bank as well as for a large Canadian pension fund.

Mr. Hudson is a Chartered Professional Accountant and holds a Master of Business Administration degree, a Master of Tax degree, and a Bachelor of Science Degree in Biochemistry.

Mr. Hudson lives in Oakville, Ontario with his lovely wife and daughter and is an avid runner and hockey player.

Treasurer. Trevor Hudson.

Toronto, Ontario

Dr. Bell is a family physician and clinical researcher in Toronto, Canada. He is Assistant Professor in the Department of Family and Community Medicine, University of Toronto and on the active staff of the Humber River Regional Hospital. He is a recipient of the Canadian College of Family Physicians Award of Excellence. His activities include:

  • Past Chair – Canadian Cardiovascular Society Antiplatelet Guideline Committee
  • Thrombosis Canada – Executive Council
  • Canadian Stroke Network Professional Development Committee
  • Canadian Medical Association Journal – Peer Reviewer

Dr. Bell’s involvement in continuing medical education includes the development and presentation of many national projects. He has served as faculty and chair of countless committees and advisory boards dedicated to serving the common interests of the medical profession and the public. His research, commentaries and letters have been presented and published internationally.

Vice President
London, Ontario

Dr. Robert Gros, elected 2019, is currently a scientist at the Robarts Research Institute and an associate professor in the Departments of Physiology and Pharmacology and of Medicine at Western University in London, Ontario. He completed his training at Western University and fellowship training at the Toronto General Hospital. He is Director of the Canada Foundation for Innovation-funded Laboratory for Cardiovascular and Metabolic Phenotyping of Genetically-modified mice. He serves as a committee member on national granting agency review panels and holds leadership roles on the Scientific Program Committees for both the Ontario Hypertension Society and Hypertension Canada. Dr. Gros served as Co-Chair of the Canadian Hypertension Congress since its inaugural event and is a Senior Mentor of the Young Investigator Forum.

The focus of Dr. Gros’ research programme is to investigate the cellular/ molecular mechanisms involved in the regulation of vascular and cardiac function.  He has a particular interest in the role and regulation of G protein-coupled receptor signaling pathways as well as the role of both the neuronal and non-neuronal cholinergic system and their contribution under physiological and pathological conditions such as hypertension and heart failure. 

Montreal, Quebec

Dr. Janusz Kaczorowski is Professor and Research Director in the Department of Family and Emergency Medicine at the Université de Montréal. Dr. Kaczorowski was elected to Hypertension Canada’s Board in 2013.

Dr. Kaczorowski is a holder of the Dr. Sadok Besrour Chair in Family Medicine and the GlaxoSmithKline-Canadian Institutes of Health Research (CIHR) chair in Optimal Management of Chronic Disease. He directs the Evaluation, Health Care Systems and Services research theme at the Université de Montréal Hospital Research Centre (CRCHUM). He plays leadership roles in the hypertension, stroke and primary care research communities in Canada. He has an active, collaborative and multi-disciplinary research agenda that includes optimal use of therapeutics in primary care, primary prevention of cardiovascular disease and stroke, knowledge transfer, health services research and population health.

Dr. Kaczorowski has over 20 years’ experience in developing, coordinating, and completing all aspects of research studies in primary care. He has held a number of large grants both as principal investigator and co-investigator and has co-authored over 200 peer-reviewed articles.

Doctor Janusz Kaczorowski.

Victoria, British Columbia

Ms. Dorothy Morris is a clinical nurse educator in cardiac surgery and coronary care at the Royal Jubilee Hospital, Victoria, British Columbia and Canadian Council of Cardiovascular Nurses (CCCN)’s National director for health promotion and advocacy. Ms. Morris was elected to Hypertension Canada’s Board in 2014.

Ms. Morris has co-authored and teaches a basic arrhythmia interpretation and management course, speaks on a variety of cardiovascular topics and has published a number of articles.

She has given numerous presentations at national and international conferences including the Canadian Association of Gerontology, The International Society of Hypertension and the Canadian Cardiovascular Congress. She contributes to the work of Hypertension Canada and the Canadian Institutes of Health Research / Heart and Stroke Foundation Chair’s Hypertension Advisory Committee.

In 2005, Ms. Morris received the award of excellence for nursing education from the college of registered nurses of British Columbia and the clinical cardiovascular excellence award from CCCN. She has also been the recipient of an award of excellence from Hypertension Canada and award of merit for workplace health innovation from the health employers association of British Columbia.

Ms. Morris has a keen interest in cardiovascular disease risk factors, health advocacy and in continuing nursing education initiatives.

Clinical Nurse Educator. Dorothy Morris.

Halifax, Nova Scotia

David currently works both as part-time General Counsel to Acadian Seaplants Limited and part- time Counsel to Irving Shipbuilding providing support for key legal issues. Previously, he was the Vice President and General Counsel at Irving Shipbuilding from 2015 to 2019. From 2001 to 2015, he was a partner in the Halifax office of Stewart McKelvey where he had a broad commercially oriented practice in maritime, construction, energy and natural resources, and environmental law. Before law, David had a career in the army as an artillery officer. He continued to serve in the Army Reserve while practicing law and after returning from a tour in Afghanistan in 2010 was invested as a member of the Order of Military Merit by the Governor-General. He retired from the Army in 2015 as a Brigadier-General after 30 years of full and part-time service. His last position was Deputy Commander for the 5th Canadian Division, essentially the Army in Atlantic Canada. He has written, presented and published papers and contributed to books on various marine and environment subjects. David is an associate of the Marine Environmental Law Institute and was a member of the part-time faculty at the Schulich School of Law where he taught Fisheries Law from 2004 to 2015. He was a member of the Transportation Appeal Tribunal of Canada from 2010 to 2017. He was appointed Queen’s Counsel in 2017.

David G. Henley

Edmonton, Alberta

Laurie is currently the Corporate Director, Quality, Patient Safety & Experience at Covenant Health, which provides acute and continuing care programs and services across the province of Alberta. Her educational background includes completion of a BSc (Eng), an MBA and a PhD (Business). Following a number of years as an engineer in the oil and gas sector, her MBA led her to a position in healthcare administration. Following completion of my doctoral program at the University of Alberta, Laurie went on to a post-doctoral fellowship at McGill University, focusing on physician practice patterns during both programs. She was subsequently awarded a Harkness Fellowship in Health Policy with The Commonwealth Fund. She has experience in academia, research and healthcare administration.

Laurel K. Taylor

Our Impact 2019

We measure our performance by our impact. Click here to view our 2019 Annual Report.

Hypertension Canada Awards

The annual awards recognize a distinguished record of substantial contributions by individual or organizations that have increased prevention and/or improved control of blood pressure in Canada. Deadline for nominations – June 7, 2020

Hypertension Innovations Award

The new annual award recognizes a member or organization that implements innovative approaches in knowledge translation and education related to hypertension and/or primary prevention.

George Fodor Award

The George Fodor Award recognizes a distinguished record of substantial contributions by individuals or organizations that have increased prevention and/or improved control of blood pressure in Canada. Contributions worthy of this prestigious award are expected to be broad in scope (i.e., national) and enduring over time, and to have had a substantive impact.

Distinguished Service Award

The Distinguished Service Award recognizes a long-standing distinguished record of service to Hypertension Canada by an individual. A nominee must have made significant voluntary service contributions to Hypertension Canada and prolonged contributions to the Canadian Hypertension Society, Blood Pressure Canada and/or Hypertension Canada Guidelines over their career.

Senior Investigator Award

The Senior Investigator Award recognizes research in hypertension or blood pressure by an individual. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.

Jacques de Champlain New Investigator Award

The Jacques de Champlain New Investigator Award recognizes excellence in the field of hypertension or blood pressure research by a new investigator, who has not exceeded a time period of 10 years from the first appointment as an independent investigator. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.

Certificates of Excellence

Throughout Canada, community, provincial, regional or national initiatives and ongoing programs of high blood pressure prevention and control are instrumental in improving the control of blood pressure. Many of these initiatives are led and contributed to by community-based organizations, individuals and volunteer efforts. These activities are essential to the health of the average Canadian by potentially lowering cardiovascular disease, but are rarely acknowledged. The Certificates of Excellence are presented to these worthy individuals or organizations in recognition of their outstanding efforts and contributions in Canada through increased public awareness, prevention or control of hypertension.

The Outstanding Volunteer Award 

The Outstanding Volunteer Award is presented to worthy individuals in recognition of their outstanding efforts and contributions to move forward the mission and vision of Hypertension Canada.